Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC
机构:[1]Hebei Med Univ, Thorac Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China河北医科大学第四医院[2]Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China河北医科大学第四医院[3]Hebei Med Univ, Second Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China河北医科大学第四医院
Accumulating evidences indicated that some microRNAs (miRNAs) play a critical role during the carcinogenesis. In the present study, we found that miR-124 is down-regulated in esophageal squamous cell carcinoma (ESCC) tissues. Three miR-124 encoding genes, including mir-124-1, mir-124-2, and mir-124-3, harboring CpG islands undergo methylation-mediated miR-124 inactivation in ESCC tissues. The methylation status of all these three genes was negatively associated with the expression of miR-124. The low expression of miR-124 and the hypermethylation of mir-124-1 and mir-124-3 were associated with the clinico-pathological parameters indicating the poor prognosis. In addition, promoter methylation of all three genes plus low expression of miR-124 was the independent poor prognostic marker for ESCC patients. In conclusion, miR-124 may function as a tumor suppressive miRNA, and hypermethylation-mediated inactivation of miR-124 may be useful for a poor prognostic marker for ESCC patients.
基金:
National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81001178]; Science Foundation of Hebei Province [16967788D]
第一作者机构:[1]Hebei Med Univ, Thorac Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构:[1]Hebei Med Univ, Thorac Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China[3]Hebei Med Univ, Second Surg, Hosp 4, Shijiazhuang 050011, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
Tian Ziqiang,Li Zhenhua,Zhu Yonggang,et al.Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC[J].CLINICAL & EXPERIMENTAL METASTASIS.2019,36(4):381-391.doi:10.1007/s10585-019-09974-1.
APA:
Tian, Ziqiang,Li, Zhenhua,Zhu, Yonggang,Meng, Lingjiao,Liu, Fei...&Wang, Guiying.(2019).Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.CLINICAL & EXPERIMENTAL METASTASIS,36,(4)
MLA:
Tian, Ziqiang,et al."Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC".CLINICAL & EXPERIMENTAL METASTASIS 36..4(2019):381-391